Reduction of monocyte chemoattractant protein-1 and interleukin-8 levels by ticlopidine in TNF-α stimulated human umbilical vein endothelial cells

Journal of Biomedicine and Biotechnology

Volumn 2009, Issue , 2009, Pages

  Hu, Chaur Jong ^a   Lee, Yueh Lun ^a   Shih, Neng Yao ^b   Yang, Yi Yuan ^a,b,c,d   Charoenfuprasert, Suparat ^a   Dai, Yu Shan ^a   Chang, Su Mei ^a   Tsai, Yu Hui ^a,c   Tseng, How ^a   Liu, Chia Yu ^e   Leu, Sy Jye ^a,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TICLOPIDINE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; TRANSCRIPTION FACTOR RELA;

ARTICLE; CELL ADHESION; CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MONOCYTE; UMBILICAL VEIN; CELL LINE; CHEMOTAXIS; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROTEIN TRANSPORT;

CELL ADHESION; CELL LINE; CHEMOKINE CCL2; CHEMOTAXIS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-8; PROTEIN TRANSPORT; RNA, MESSENGER; TICLOPIDINE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 75149190143     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2009/917837     Document Type: Article

References (63)

1. Terkeltaub R., Boisvert W. A., Curtiss L. K., Chemokines and atherosclerosis Current Opinion in Lipidology 1998 9 5 397 405
2. Reape T. J., Groot P. H. E., Chemokines and atherosclerosis Atherosclerosis 1999 147 2 213 225
3. Dosquet C., Weill D., Wautier J. L., Cytokines and thrombosis Journal of Cardiovascular Pharmacology 1995 25 supplement 2 S13 S19
4. Braunersreuther V., Mach F., Steffens S., The specific role of chemokines in atherosclerosis Thrombosis and Haemostasis 2007 97 5 714 721
5. Navab M., Imes S. S., Hama S. Y., Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein Journal of Clinical Investigation 1991 88 6 2039 2046
6. Adams D. H., Lloyd A. R., Chemokines: leucocyte recruitment and activation cytokines The Lancet 1997 349 9050 490 495
7. Baggiolini M., Dewald B., Moser B., Human chemokines: an update Annual Review of Immunology 1997 15 675 705
8. Sica A., Wang J. M., Colotta F., Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor Journal of Immunology 1990 144 8 3034 3038
9. Rollins B. J., Yoshimura T., Leonard E. J., Pober J. S., Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE American Journal of Pathology 1990 136 6 1229 1233
10. Satriano J. A., Shuldiner M., Hora K., Xing Y., Shan Z., Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase Journal of Clinical Investigation 1993 92 3 1564 1571
11. Yla-Herttuala S., Lipton B. A., Rosenfeld M. E., Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions Proceedings of the National Academy of Sciences of the United States of America 1991 88 12 5252 5256
12. Nelken N. A., Coughlin S. R., Gordon D., Wilcox J. N., Monocyte chemoattractant protein-1 in human atheromatous plaques Journal of Clinical Investigation 1991 88 4 1121 1127
13. Takeya M., Yoshimura T., Leonard E. J., Takahashi K., Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody Human Pathology 1993 24 5 534 539
14. Seino Y., Ikeda U., Takahashi M., Expression of monocyte chemoattractant protein-1 in vascular tissue Cytokine 1995 7 6 575 579
15. Baggiolini M., Dewald B., Moser B., Interleukin-8 and related chemotactic cytokinesCXC and CC chemokines Advances in Immunology 1994 55 97 179
16. Boisvert W. A., Santiago R., Curtiss L. K., Terkeltaub R. A., A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice Journal of Clinical Investigation 1998 101 2 353 363
17. Boisvert W. A., Curtiss L. K., Terkeltaub R. A., Interleukin-8 and its receptor CXCR2 in atherosclerosis Immunologic Research 2000 21 2-3 129 137
18. Gonzalez E. R., Kannewurf B. S., Atherosclerosis: a unifying disorder with diverse manifestations American Journal of Health-System Pharmacy 1998 55 19, supplement 1 S4 S7
19. Koch A. E., Kunkel S. L., Pearce W. H., Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms American Journal of Pathology 1993 142 5 1423 1431
20. Blankenberg S., Barbaux S., Tiret L., Adhesion molecules and atherosclerosis Atherosclerosis 2003 170 2 191 203
21. Tian J., Pei H., James J. C., Circulating adhesion molecules in apoE-deficient mouse strains with different atherosclerosis susceptibility Biochemical and Biophysical Research Communications 2005 329 3 1102 1107
22. Ramos C. L., Huo Y., Jung U., Direct demonstration of P-selectin-and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice Circulation Research 1999 84 11 1237 1244
23. OBrien K. D., Allen M. D., McDonald T. O., Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: implications for the mode of progression of advanced coronary atherosclerosis Journal of Clinical Investigation 1993 92 2 945 951
24. Cybulsky M. I., Iiyama K., Li H., A major role for VCAM-1, but not ICAM-1, in early atherosclerosis Journal of Clinical Investigation 2001 107 10 1255 1262
25. Quinn M. J., Fitzgerald D. J., Ticlopidine and clopidogrel Circulation 1999 100 15 1667 1672
26. Gent M., Blakely J. A., Easton J. D., The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke The Lancet 1989 1 8649 1215 1220 (Pubitemid 19140324)
27. Bellavance A., Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study Stroke 1993 24 10 1452 1457
28. Yang Y.-Y., Hu C.-J., Chang S.-M., Tai T.-Y., Leu S.-J., Aspirin inhibits monocyte chemoattractant protein-1 and interleukin-8 expression in TNF-stimulated human umbilical vein endothelial cells Atherosclerosis 2004 174 2 207 213
29. Hayes I. M., Jordan N. J., Towers S., Human vascular smooth muscle cells express receptors for CC chemokines Arteriosclerosis, Thrombosis, and Vascular Biology 1998 18 3 397 403
30. Lagoo-Deenadayalan S., Lagoo A. S., Barber W. H., Hardy K. J., A standardized approach to PCR-based semiquantitation of multiple cytokine gene transcripts from small cell samples Lymphokine and Cytokine Research 1993 12 2 59 67
31. Stern J. L., Slobedman B., Human cytomegalovirus latent infection of myeloid cells directs monocyte migration by up-regulating monocyte chemotactic protein-1 Journal of Immunology 2008 180 10 6577 6585
32. Huber T. B., Reinhardt H. C., Exner M., Expression of functional CCR and CXCR chemokine receptors in podocytes Journal of Immunology 2002 168 12 6244 6252
33. Santos M. I., Fuchs S., Gomes M. E., Unger R. E., Reis R. L., Kirkpatrick C. J., Response of micro-and macrovascular endothelial cells to starch-based fiber meshes for bone tissue engineering Biomaterials 2007 28 2 240 248
34. Chen K.-L., Liu W.-H., Yang Y.-Y., Leu S.-J. C., Shih N.-Y., Characterization of novel transforming growth factor-beta type I receptors found in malignant pleural effusion tumor cells BMC Molecular Biology 2007 8, article 72
35. Weber C., Erl W., Pietsch A., Weber P. C., Aspirin inhibits nuclear factor-B mobilization and monocyte adhesion in stimulated human endothelial cells Circulation 1995 91 7 1914 1917
36. Klein-Soyer C., Cazenave J.-P., Herbert J.-M., Maffrand J.-P., SR 25989 inhibits healing of a mechanical wound of confluent human saphenous vein endothelial cells which is modulated by standard heparin and growth factors Journal of Cellular Physiology 1994 160 2 316 322
37. Di Perri T., Pasini F. L., Frigerio C., Pharmacodynamics of ticlopidine in man in relation to plasma and blood cell concentration European Journal of Clinical Pharmacology 1991 41 5 429 434
38. Harris P., Ralph P., Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines Journal of Leukocyte Biology 1985 37 4 407 422
39. Carvalho D., Savage C. O. S., Black C. M., Pearson J. D., IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro: induction of adhesion molecule expression and involvement of endothelium-derived cytokines Journal of Clinical Investigation 1996 97 1 111 119
40. Lazzarino D. A., de Diego M., Hirschman S. Z., IL-8 and MCP-1 secretion is enhanced by the peptide-nucleic acid immunomodulator, product R, in U937 cells and primary human monocytes Cytokine 2001 14 4 234 239
41. Kopp E., Ghosh S., Inhibition of NF-B by sodium salicylate and aspirin Science 1994 265 5174 956 959
42. Navab M., Hama S. Y., Nguyen T. B., Fogelman A. M., Monocyte adhesion and transmigration in atherosclerosis Coronary Artery Disease 1994 5 3 198 204
43. Siegel-Axel D. I., Gawaz M., Platelets and endothelial cells Seminars in Thrombosis and Hemostasis 2007 33 2 128 135
44. May A. E., Langer H., Seizer P., Bigalke B., Lindemann S., Gawaz M., Platelet-leukocyte interactions in inflammation and atherothrombosis Seminars in Thrombosis and Hemostasis 2007 33 2 123 127
45. Gawaz M., Langer H., May A. E., Platelets in inflammation and atherogenesis Journal of Clinical Investigation 2005 115 12 3378 3384
46. Steinhubl S. R., Moliterno D. J., The role of the platelet in the pathogenesis of atherothrombosis American Journal of Cardiovascular Drugs 2005 5 6 399 408
47. Gerszten R. E., Mach F., Sauty A., Rosenzweig A., Luster A. D., Chemokines, leukocytes, and atherosclerosis Journal of Laboratory and Clinical Medicine 2000 136 2 87 92
48. Rollins B. J., Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease Molecular Medicine Today 1996 2 5 198 204
49. Gu L., Okada Y., Clinton S. K., Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice Molecular Cell 1998 2 2 275 281
50. Boring L., Gosling J., Chensue S. W., Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice Journal of Clinical Investigation 1997 100 10 2552 2561
51. Boring L., Gosling J., Cleary M., Charo I. F., Decreased lesion formation in CCR 2-/-mice reveals a role for chemokines in the initiation of atherosclerosis Nature 1998 394 6696 894 897
52. Veillard N. R., Steffens S., Pelli G., Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo Circulation 2005 112 6 870 878
53. Strieter R. M., Polverini P. J., Kunkel S. L., The functional role of the ELR motif in CXC chemokine-mediated angiogenesis Journal of Biological Chemistry 1995 270 45 27348 27357
54. Belperio J. A., Keane M. P., Arenberg D. A., CXC chemokines in angiogenesis Journal of Leukocyte Biology 2000 68 1 1 8
55. Addison C. L., Daniel T. O., Burdick M. D., The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR + CXC chemokine-induced angiogenic activity Journal of Immunology 2000 165 9 5269 5277
56. Simonini A., Moscucci M., Muller D. W. M., IL-8 is an angiogenic factor in human coronary atherectomy tissue Circulation 2000 101 13 1519 1526
57. Hass W. K., Easton J. D., Adams H. P. Jr., A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients New England Journal of Medicine 1989 321 8 501 507
58. Jawien J., Csanyi G., Gajda M., Mateuszuk L., Lomnicka M., Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice European Journal of Pharmacology 2007 556 13 129 135
59. Kunsch C., Rosen C. A., NF-B subunit-specific regulation of the interleukin-8 promoter Molecular and Cellular Biology 1993 13 10 6137 6146
60. Yasumoto K., Okamoto S.-I., Mukaida N., Murakami S., Mai M., Matsushima K., Tumor necrosis factor and interferon synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene Journal of Biological Chemistry 1992 267 31 22506 22511
61. Freter R. R., Alberta J. A., Hwang G. Y., Wrentmore A. L., Stiles C. D., Platelet-derived growth factor induction of the immediate-early gene MCP-1 is mediated by NF-B and a 90-kDa phosphoprotein coactivator Journal of Biological Chemistry 1996 271 29 17417 17424
62. Amberger A., Hala M., Saurwein-Teissl M., Suppressive effects of anti-inflammatory agents on human endothelial cell activation and induction of heat shock proteins Molecular Medicine 1999 5 2 117 128
63. Jawien J., Gajda M., Mateuszuk L., Inhibition of nuclear factor-B attenuates artherosclerosis in apoE/LDLRdouble knockout mice Journal of Physiology and Pharmacology 2005 56 3 483 489